Product image of Wilate (Human Coagulation Factor Viii, Human Von Willebrand Factor) supplied by GNH India

Wilate

Active Ingredient:
Human Coagulation Factor Viii, Human Von Willebrand Factor
Origin:
EU

Wilate (Human Coagulation Factor Viii, Human Von Willebrand Factor)

Wilate is a human-derived coagulation factor VIII and von Willebrand factor concentrate used to manage bleeding disorders. This intravenous therapy supports hemostasis in conditions like hemophilia A and von Willebrand disease. Ideal for patients requiring reliable clotting support.

Manufacturer / TM Owner

Octapharma (Ip) Sprl

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Wilate is used to treat and prevent bleeding episodes in patients with hemophilia A or von Willebrand disease. It helps restore normal clotting function by providing essential clotting factors. This medication is administered intravenously under medical supervision. Commonly prescribed for routine prophylaxis or on-demand treatment.

Side Effects

  • Wilate works by replenishing missing or deficient clotting factors in the bloodstream. Patients may experience improved clotting ability following administration. Effects vary based on individual conditions and dosing. Regular use may help reduce the frequency of bleeding episodes.

Precautions & Warnings

  • Store Wilate in a refrigerator at 2–8°C (36–46°F) and protect from light. Do not freeze or shake the vial. Use only if the solution is clear and free of particles. Discard any unused portion after administration. Always follow healthcare provider instructions for safe handling and disposal.

Avoid Interactions

  • Wilate may interact with other medications affecting blood clotting, such as anticoagulants or antiplatelet drugs. Avoid alcohol and herbal supplements that may increase bleeding risk. Consult a healthcare provider before combining with other therapies. No known severe drug-drug interactions have been reported.

Frequently Asked Questions

Wilate is used to treat and prevent bleeding in patients with hemophilia A or von Willebrand disease by providing clotting factors.

Wilate is given as an intravenous infusion under medical supervision, typically in a clinical or home setting.

No, Wilate contains Factor VIII and von Willebrand factor, which are not indicated for hemophilia B (Factor IX deficiency).

Yes, Wilate is a prescription medication and should only be used under the guidance of a healthcare professional.

Wilate must be refrigerated at 2–8°C (36–46°F) and used before the expiration date on the vial.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Human Coagulation Factor Viii, Human Von Willebrand Factor

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT